rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6
|
pubmed:dateCreated |
1998-4-29
|
pubmed:abstractText |
Human ovarian cancer cells were evaluated to determine whether combination treatment with mild hyperthermia and cisplatin could inhibit repair of sublethal radiation damage.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0344-5704
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
41
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
491-6
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9554594-Animals,
pubmed-meshheading:9554594-Cell Survival,
pubmed-meshheading:9554594-Cisplatin,
pubmed-meshheading:9554594-Combined Modality Therapy,
pubmed-meshheading:9554594-DNA Repair,
pubmed-meshheading:9554594-Drug Resistance, Neoplasm,
pubmed-meshheading:9554594-Female,
pubmed-meshheading:9554594-Humans,
pubmed-meshheading:9554594-Hyperthermia, Induced,
pubmed-meshheading:9554594-Ovarian Neoplasms,
pubmed-meshheading:9554594-Radiation Tolerance,
pubmed-meshheading:9554594-Radiation-Sensitizing Agents,
pubmed-meshheading:9554594-Tumor Cells, Cultured,
pubmed-meshheading:9554594-X-Rays
|
pubmed:year |
1998
|
pubmed:articleTitle |
Interactions of mild hyperthermia, cisplatin and split dose irradiation in human ovarian carcinoma cells.
|
pubmed:affiliation |
Medical Physics Department, Ottawa Regional Cancer Centre, Ontario, Canada.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|